NCT01544543

Brief Summary

VESALIO is a pilot study aimed at evaluating the feasibility and reliability (time stability and interobserver reliability) of healthcare quality standards in chronic obstructive pulmonary disease (COPD) recently outlined by SEPAR (Spanish Pneumology and Thoracic Surgery Society), and at establishing the foundation for a future validation (construct and criterion validation) of the aforementioned standards.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 21, 2012

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 6, 2012

Completed
Last Updated

March 6, 2012

Status Verified

February 1, 2012

First QC Date

February 21, 2012

Last Update Submit

March 5, 2012

Conditions

Keywords

COPD

Outcome Measures

Primary Outcomes (3)

  • COPD exacerbation

    Within 12 months after hospitalization

  • Mortality

    within 90 and 180 days after hospitalization

  • Healthcare-associated cost

    Hospital-stay lenght ER visits

    within 12 months after hospitalization

Study Arms (1)

COPD Exacerbation Cohort

Patients hospitalized for a COPD exacerbation

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

COPD patients hospitalized for an exacerbation of COPD

You may qualify if:

  • Men and women 40 years of age or older
  • Diagnosis of COPD at hospital discharge
  • Hospitalization for a COPD exacerbation

You may not qualify if:

  • Patients hospitalized for the first time at the participating site without a documented history of COPD
  • Patients currently participating of having ever participated in a COPD-related clinical trial
  • Patients with a serious disease that might affect the measured outcomes (terminal oncologic disease, neoplastic disease for which the patient is receiving chemo/radiotherapy, terminal renal insufficiency, AIDS)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital General de Requena

Requena, Valencia, 46340, Spain

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Juan J Soler Cataluna, MD, PhD

    Hospital de Requena, Valencia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

February 21, 2012

First Posted

March 6, 2012

Study Start

February 1, 2010

Last Updated

March 6, 2012

Record last verified: 2012-02

Locations